share_log

科创板晚报|九号公司去小米化后上半年净利同比增超167% 海尔生物股东拟询价转让2%股份

Star evening news | After No. 9 company's de-Xiaomi transformation, net profit in the first half of the year increased by over 167% year-on-year. Qingdao Haier Biomedical Co., Ltd.'s shareholder intends to inquire about transferring 2% of its shares.

cls.cn ·  Aug 6 20:40

1. National Enterprises should give full play to the role of block orders in the key areas of technological innovation. 2. Three departments should carry out collaborative planning and layout of computing power and power infrastructure. 3. The Ministry of Industry and Information Technology should orderly promote the reform of the access system for satellite internet services.

Today's Science and Technology Innovation Board Daily News August 6th includes: the State-Owned Assets Supervision and Administration Commission: National Enterprises should give full play to the role of block orders in the key areas of technological innovation; three departments should carry out collaborative planning and layout of computing power and power infrastructure; the Ministry of Industry and Information Technology should orderly promote the reform of the access system for satellite internet services.

Focus on hot topics

Briefs:

The State-owned Assets Supervision and Administration Commission: National Enterprises should give full play to the role of block orders in the key areas of technological innovation such as satellite navigation, chips, high-end CNC machine tools, and industrial robots.

The State-owned Assets Supervision and Administration Commission of the State Council issued the Guidelines on Standardizing the Procurement Management of Central Enterprises. For innovative products and services created by original technology source enterprises, innovation consortia, start-up enterprises listed in the relevant catalogues of industrial and information departments, and the achievements included in the Catalogue of Recommended Achievements in Science and Technology Innovation of Central Enterprises, the enterprises can choose either negotiation or direct procurement methods to purchase them, while reserving procurement quotas and giving priority to the trial and use of these achievements, without setting discriminatory evaluation criteria. In the key areas of science and technology innovation such as satellite navigation, chips, high-end CNC machine tools, industrial robots, and advanced medical devices, central enterprises should give full play to the role of block orders and take the lead in using innovative products.

Three departments should coordinate the development needs of data centers and the resource endowment of new energy, and carry out collaborative planning and layout of computing power and power infrastructure.

The National Development and Reform Commission, the National Energy Administration, and the National Bureau of Statistics have issued the Action Plan for Accelerating the Construction of a New Power System (2024-2027), which proposes the implementation of a batch of projects for the collaboration of computing power and power. The plan is to coordinate the development needs of data centers and the resource endowment of new energy, scientifically integrate source-load-storage resources, carry out collaborative planning and layout of computing power and power infrastructure, explore the 'green power aggregation supply' mode of nearby power supply, aggregated trading, and local absorption, and integrate regulation resources to improve the level of collaboration between computing power and power, increase the proportion of green power in data centers, and reduce the demand for grid capacity. It also explores the stable supply mode of green electricity through joint operation of concentrated solar power and wind power, photovoltaic power generation. It strengthens the utilization of waste heat resources in data centers to meet the heat demand of surrounding areas.

MIIT: Further pilot to expand value-added telecommunications business openness and orderly promote the reform of satellite internet business access system.

The Ministry of Industry and Information Technology has issued opinions on innovating the management of the information and communication industry and optimizing the business environment, accelerating the revision of the "Telecommunications Service Classification Catalog", promoting better business classification and definition to meet the needs of new technology and business development, and supporting enterprise innovation and development. We will overall plan and carry out the commercial pilot of new telecommunications services, and support relevant regions and enterprises to carry out business innovation in an orderly manner on the premise of ensuring safety. We will speed up the formulation of supporting policies for the innovative development of new technologies and new businesses, and encourage enterprises to further deepen their technological innovation and industrial application in emerging fields such as 5G, AI, and quantum information. We will promote the formation of a high-level new opening up and further pilot and expand the opening up of value-added telecommunications services. We will deepen the opening up of telecommunications services to private capital, increase support for private enterprises to participate in the innovation of business and services such as mobile communication resale, and promote the reform of the access system for satellite internet services in an orderly manner to better support the development of private telecommunications enterprises.

Sichuan will form a world-class nuclear medical industry development highland by 2030.

The Sichuan Provincial Government recently issued the Opinions on Promoting the High-quality Development of the Nuclear Medical Industry, proposing that Sichuan should achieve the independent supply of more than 10 major medical isotopes domestically in 2027, complete or enter clinical trials of more than 5 radioactive drugs and high-end nuclear medical equipment, form a standard system for medical isotopes, radioactive drugs, and nuclear medical equipment, establish a perfect clinical transformation and research and development system for nuclear medicine, and build a leading domestic nuclear medical industry cluster.

Insiders: Taiwan Semiconductor's 5/3 nanometer process products will continue to rise in price by about 3-8% in 2025.

According to IC design industry insiders, TSMC will not only increase prices in 2024, but also inform multiple customers successively in July that the 5/3 nanometer process will see a price increase in 2025 due to constantly soaring costs, with a range of 3-8%. This move places tremendous pressure on the 53% gross margin, which has successfully been shifted onto customers. Industry insiders point out that TSMC, which has received orders for AI and HPC fields, has also entered the peak season for consumer electronics shipments and secured large orders from Apple, Qualcomm, MediaTek, as well as Intel, AMD, Nvidia, and Broadcom. 3/5 nanometer production capacity will continue to be fully loaded, and TSMC is expanding production capacity to respond to strong customer demand.

Three key figures of OpenAI have left the company at the same time recently.

According to reports, Greg Brockman, one of the eleven co-founders of OpenAI, is on long-term leave; John Schulman, another co-founder and key leader, has jumped to OpenAI's competitor Anthropic; Peter Deng, the product manager who joined the company last year, has led the product development of Meta Platforms, Uber, and Airtable, but he has also resigned. In addition, OpenAI recently reassigned another security manager, Aleksander Madry, to another position. Co-founder Ilya Sutskever recently resigned and set up a start-up company. Another co-founder, Andrej Karpathy, left in February and founded an educational start-up company.

In-depth analysis:

The Ministry of Industry and Information Technology promotes the reform of the access system and under the warm policy, satellite internet may 'take off'.

OpenAI is facing personnel instability as Altman's "close ally" takes a long vacation and ChatGPT architect switches to a competitor.

Demand remains strong, Taiwan Semiconductor's 5/3nm process quotes will continue to rise next year.

From 'person waiting for the vaccine' to 'vaccine waiting for people', what is the solution to the dilemma of the Chinese-made 9-valent HPV vaccine?

Tencent has made its first move, and the dark side of the moon has once again received financing six months later, with a valuation exceeding 23 billion.

Announcement of the Science and Technology Innovation Board

In the first half of the year, 9 Corporation achieved a net profit of 596 million yuan, with no dependence on a single major customer after non-mi-ization.

On August 6, Jiuhao Company (689009.SH) released its 2024 interim report. The report shows that in the first half of this year, the company achieved operating income of RMB 6.666 billion, a year-on-year increase of 52.2%, and achieved a net profit attributable to shareholders of RMB 0.596 billion, a year-on-year increase of 167.82%. In the first half of this year, Jiuhao Company focused on the innovative short-distance transportation and service robot main business, and various product lines have highlights, driving the company to achieve autonomous brand revenue of RMB 5.86 billion, a year-on-year increase of 82%. Although Jiuhao Company did not separately disclose the proportion of Xiaomi channel revenue in the semi-annual report, from the 2023 annual report, the proportion of distribution income of Xiaomi customized products in the total revenue of Jiuhao Company has dropped to 4.3%. The company no longer has a single large customer dependency label. As a model of Xiaomi's ecological chain, Jiuhao Company has already realized a benign “graduation” under Xiaomi's early support.

Dareway Software: Net income in the first half of the year was 20.8554 million yuan, a year-on-year increase of 3.23%.

Dareway Software released its 2024 semi-annual report, achieving revenue of 208 million yuan, a year-on-year increase of 3.15%. The net income attributable to shareholders of the listed company was 20.8554 million yuan, a year-on-year increase of 3.23%.

Haier Biomedical: Shareholders plan to transfer 6.35905 million shares, accounting for 2.00% of the total share capital, via inquiry at a low price due to its own capital needs.

Haier Bio announced that its shareholder Ningbo Meishan Free Trade Port Zone Qijun Equity Investment Partnership Enterprise (Limited Partnership) plans to transfer 6.35905 million shares, accounting for 2.00% of the total share capital, through inquiry at a low price, and the transfer price will not be lower than 70% of the average price of the previous 20 trading days. The transfer price will be determined based on effective subscription. The transferee shall be an institutional investor with corresponding pricing ability and risk-bearing capacity.

JinGuan Electric: Won the bid for a Lightning Arrester Project on the line worth 25.9384 million yuan.

Jinguang Electric announced that it won the bid for the 500 kV line arrester and 35 kV-220 kV line arrester products in the first batch of the main grid line material framework tender project of the Southern Power Grid Company in 2024, with a total estimated bid amount of RMB 25.9384 million. The bid amount of this bidding accounts for about 4.02% of the operating income of 2023 and will have a positive impact on the company's future operating performance. However, the company has not signed a formal contract with the tenderer for the bid project, and there is uncertainty.

Junpu Asia Vets: intends to repurchase shares through centralized bidding to use for employee shareholding plans or stock-based incentives.

Junpu Intelligence announced that the company intends to repurchase shares through centralized bidding, with a total repurchase amount not less than 30 million yuan(inclusive) and not more than 50 million yuan(inclusive), sourced from the company's own funds and oversubscribed funds. The repurchased shares will be used for employee shareholding plans or stock-based incentives. The repurchase price does not exceed RMB 5.8 per share(inclusive). The repurchase period shall not exceed 12 months from the date of approval of this repurchase plan by the board of directors.

Haitian Reishi: controlling shareholder proposed to buy back 10 million to 20 million yuan of shares.

Peking Haitian AAC Tech Co., Ltd. announced that it has received a proposal from Ms. He Lin, the company's controlling shareholder, actual controller, and chairman, to repurchase company shares. Based on her confidence in the company's future development and recognition of its value, Ms. He proposed that the company repurchase shares through centralized competitive transaction methods and use them all for stock-based incentives or employee stock ownership plans at suitable future opportunities. The total amount of funds for repurchasing shares shall not be less than RMB 10 million (inclusive) nor exceed RMB 20 million (inclusive), and the repurchase price shall not be higher than 150% of the average stock trading price of the company's previous 30 trading days before the board of directors approved the share repurchase plan. Ms. He promised to vote in favor of the company's share repurchase proposal at the board of directors meeting.

Suzhou Harmontronics Automation Technology intends to acquire 26% equity of its subsidiary Borui autos for 7.19 million yuan.

Suzhou Harmontronics Automation Technology announced that the company plans to use its own assets of 7.19 million yuan to acquire 26% of the equity of its controlling subsidiary, Borui Motors. After the completion of this trade, the company's direct stake in Borui Motors will increase from 55% to 81%. This transaction constitutes a related party transaction but not a major asset restructuring. The company has obtained approval from the Independent Directors' Meeting, the Board of Directors, and the Supervisory Committee, and it is not necessary to submit it to the Shareholders' Meeting for approval.

Huayu Pharmaceutical: The registration certificate for injectable levocarnitine calcium and other drugs has been obtained.

Huayu Pharmaceutical announced that injectable levocarnitine calcium and methotrexate injection have obtained drug registration certificates. Levocarnitine calcium is a folate analogue that, in combination with 5-fluorouracil chemotherapy drugs, is used to treat gastric cancer and colorectal cancer. Methotrexate has broad-spectrum anti-tumor activity and can be used alone to treat breast cancer, gestational trophoblastic tumors, etc.

Venture Capital Wind Vane

Did Tencent participate in the $0.3 billion financing of the unicorn startup Dark Side of the Moon? Insider confirms it's true.

Recently, there was news that Tencent participated in the US$300 million financing of Moonshot AI, a domestic large-scale unicorn and Kimi intelligent assistant development company, which increased its valuation to US$3.3 billion. In response to this, insiders close to the company told the 'Science and Technology Innovation Board Daily' that the news of Tencent's participation was true. Moonshot AI responded to the 'Science and Technology Innovation Board Daily' reporter that it would not comment on the financing news.

Erwei Semiconductor completes Pre-A round of financing.

Recently, Erwei Semiconductor completed a Pre-A round of financing, with investment from Zhuoyuan Asia and Jinyu Mao. The funds from this round of financing will be used to increase research and development investment, further expand the market, and upgrade the team. Erwei Semiconductor is a technology innovation enterprise focusing on the development and manufacturing of front-end process inspection equipment for integrated circuits. It has top domestic technology development capabilities and solid equipment mass production experience. Previously, Erwei Semiconductor had completed seed and seed+ rounds of financing.

Lightmed Medical completes hundreds of millions of yuan of equity financing.

Recently, Shanghai Lightmed Medical Technology Co., Ltd. completed a hundred million yuan of equity financing. The lead investor of this round of financing is Shanghai Biomedical Fund and Dongfang Fuhai followed the investment. Lightmed Medical was established in 2021 and is a developer of medical molecular imaging equipment, focusing on original innovation and development of digital molecular imaging equipment, mainly producing personalized molecular imaging equipment and related products, which can be used for screening and testing of more than 100 diseases. Previously, Lightmed Medical had completed angel rounds of financing.

Yunshenchu has received a C round of investment.

Recently, business change information shows that Hangzhou Yunshenchu Technology Co., Ltd. (DeepRobotics) has completed a C round of financing, and new investors include Hansong Capital Management, Huajian Function Investment, Shenzhicheng Group, and Moganshan High-Tech Investment. Yunshenchu is a technology company focusing on the research and development of intelligent quadruped robot products. Its founding team is composed of personnel from Zhejiang University, and it has rich experience in the R&D of legged robot.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment